Background: White matter hyperintensities (WMH) are commonly observed on MRI in Alzheimer's disease (AD), but the molecular pathways underlying their relationships with the ATN biomarkers remain unclear. The aim of this study was to identify genetic variants that may modify the relationship between WMH and the ATN biomarkers.
Method: This genome-wide interaction study (GWIS) included individuals with AD, MCI, and normal cognition from ADNI (n = 1012). WMH were measured from FLAIR MRI using an automated atlas-based segmentation. CSF Aβ42, tau, and p-tau concentrations were measured using Roche Elecsys immunoassays. Hippocampal volumes were obtained using FreeSurfer. Interaction effects between single nucleotide polymorphisms (SNP) and WMH volumes on ATN biomarkers were assessed using linear regression models, adjusting for age, sex, diagnosis, MMSE, APOE-ε4 status, head-size, and 4 genetic principal components in PLINK2. Linkage disequilibrium-based clumping (LD: 0.5; physical distance: 250kb) was performed in PLINK1.9, visualized with LocusZoom. Significant SNP-WMH interactions discovered in ADNI were validated in participants from the Sunnybrook Dementia Study (n = 433) and UK Biobank (n = 16720).
Result: A 30-SNP intergenic locus on chromosome 18 (lowest p-value-SNP: rs72899960 T>A, β = 227.0 pg/ml, SE = 10.2, p = 2.30 × 10, MAF = 11.1%, Imputation-R>0.99%, n = 848) achieved genome-wide significance interacting with WMH to predict Aβ42, with the nearest gene being a novel long noncoding RNA (lncRNA), ENSG00000286844 (-360KB). A 9-SNP intronic locus on chromosome 11 (lowest p-value-SNP: rs3912008 C>T, β = 0.25 cm, SE = 0.044, p = 1.47 × 10, MAF = 22.6%, Imputation-R>99%, n = 987) achieved genome-wide significance interacting with WMH to predict hippocampal volume, and was found within the microRNA gene MIR4300HG. Both SNPs showed additive moderation effects such that associations between WMH and ATN markers in major allele homozygotes were diminished in heterozygotes, and diminished further in minor allele homozygotes. The interaction between MIR4300HG-rs3912008 and WMH in predicting hippocampal volume replicated in dominant models in both the Sunnybrook Dementia Study (F = 7.98, coefficient = 0.14 cm, SE = 0.05, p = 0.005) and in UK Biobank (F = 5.32, coefficient = 0.025 cm, SE = 0.011, p = 0.021).
Conclusion: Genomic variants moderate relationships between WMH and ATN biomarkers suggesting a novel regulatory role for a long non-coding RNA, and the involvement of microRNA MIR4300HG. This interaction study may help identify the contribution of specific genes and the potential pathways involved in the relationships between WMH and AD biomarkers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.084982 | DOI Listing |
Background: Despite significant advancements in the development of blood biomarkers for AD, challenges persist due to the complex interplay of genetic and environmental risk factors in AD pathogenesis. Epigenetic processes, including non-coding RNAs and especially microRNAs (miRs), have emerged as important players in the molecular mechanisms underlying neurodegenerative diseases. MiRs have the ability to fine-tune gene expression and proteostasis, and microRNAome profiling in liquid biopsies is gaining increasing interest since changes in miR levels can indicate the presence of multiple pathologies.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Background: White matter hyperintensities (WMH) are commonly observed on MRI in Alzheimer's disease (AD), but the molecular pathways underlying their relationships with the ATN biomarkers remain unclear. The aim of this study was to identify genetic variants that may modify the relationship between WMH and the ATN biomarkers.
Method: This genome-wide interaction study (GWIS) included individuals with AD, MCI, and normal cognition from ADNI (n = 1012).
Alzheimers Dement
December 2024
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Centre for Ageing and Health (AgeCap) at the University of Gothenburg, Gothenburg, Sweden., Gothenburg, Vastra Gotaland, Sweden.
Background: C-reactive protein (CRP) is an inflammatory biomarker that has been associated with an increased risk of future cognitive decline, alongside other biomarkers such as β-amyloid (Aβ). We sought to explore the relationship between CRP levels and the amyloid/tau/neurodegeneration (A/T/N) groups in elderly individuals with and without APOE-ε4.
Method: From 1203 participants of the Gothenburg H70 Birth Cohort study, born in 1944, plasma CRP levels were collected among 300 participants (159 men & 141 women) who did not have dementia.
Alzheimers Dement
December 2024
Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Background: Early Onset Alzheimer's Disease (EOAD) is thought to result from a combination of environmental, genetic, and lifestyle factors. Herpesvirus infections may contribute to the development of EOAD and the objective of our study is to identify potential associations between herpes virus infections and the risk of developing EOAD.
Method: Amyloid-status Alzheimer's disease was diagnosed based on clinical history and ATN criteria, determined by the measuring the Amyloidß42:40 ratio, tau, and 181-Phospho-tau in the cerebrospinal fluid.
Alzheimers Dement
December 2024
Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
Background: Subjective Cognitive Decline (SCD) may represent the initial symptom of Alzheimer's disease (AD), but SCD may be absent and/or unrelated to actual cognitive decline. Objective Subtle Cognitive Decline (obj-SCD) can be identified through longitudinal standardized neuropsychological tests in individuals not yet meeting criteria for Mild Cognitive Impairment (MCI). We argue that the relationship between SCD and obj-SCD might help to inform clinical and research criteria in pre-MCI stages.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!